Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AEGON LTD. Interim / Quarterly Report 2012

Aug 9, 2012

30489_ir_2012-08-09_935dd590-bb95-4f38-8aa9-954864616a8a.pdf

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

AEGON
THE HAGUE, AUGUST 9, 2012

img-0.jpeg

CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS

Q2 2012

LIFE INSURANCE
PENSIONS
ASSET MANAGEMENT


.


Table of contents

CONDENSED CONSOLIDATED INCOME STATEMENT P 2
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME P 3
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION P 4
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY P 5
CONDENSED CONSOLIDATED CASH FLOW STATEMENT P 6
NOTES TO THE CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS P 7

Unaudited
AEGON
page 1


CONDENSED CONSOLIDATED INCOME STATEMENT

EUR millions (except per share data) Notes Q2 2012 Q2 2011 YTD 2012 YTD 2011
Premium income 4 4,597 4,501 10,448 10,778
Investment income 5 2,200 2,099 4,276 4,210
Fee and commission income 469 428 934 888
Other revenues 3 2 5 4
Total revenues 7,269 7,030 15,663 15,880
Income from reinsurance ceded 6 1,080 477 2,033 907
Results from financial transactions 7 (1,944) 932 5,621 2,045
Other income 8 2 (3) 2 34
Total income 6,407 8,436 23,319 18,866
Benefits and expenses 9 5,898 7,759 22,062 17,618
Impairment charges / (reversals) 10 52 106 98 170
Interest charges and related fees 126 117 258 228
Other charges 11 - (7) 18 21
Total charges 6,076 7,975 22,436 18,037
Share in net result of associates 7 12 18 17
Income before tax 338 473 901 846
Income tax (expense) / benefit (84) (69) (126) (115)
Net income 254 404 775 731
Net income attributable to:
Equity holders of AEGON N.V. 254 403 775 730
Non-controlling interests - 1 - 1
Earnings and dividend per share (EUR per share)
Basic earnings per share^{1} 0.08 (0.04) 0.33 (0.09)
Diluted earnings per share^{1} 0.08 (0.04) 0.33 (0.09)
Dividend per common share^{2} 0.10 - 0.10 -
Earnings per common share calculation
Net income 254 403 775 730
Preferred dividend (59) (59) (59) (59)
Coupons on other equity instruments (51) (43) (98) (87)
Coupons and premium on convertible core capital securities - (375) - (750)
Earnings attributable to common shareholders 144 (74) 618 (166)
Weighted average number of common shares outstanding 1,886 1,880 1,883 1,823

1 After deduction of preferred dividend, coupons on other equity instruments and coupons and premium on core capital securities.
2 Dividend per common share of EUR 0.10 reflects the 2012 interim dividend. The interim dividend will be paid in cash or stock at the election of the shareholder. The interim dividend will be payable as of September 14, 2012.

Local knowledge. Global power.

Unaudited


CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

EUR millions Q2 2012 Q2 2011 YTD 2012 YTD 2011
Net income 254 404 775 731
Other comprehensive income:
Gains / (losses) on revaluation of available-for-sale investments 1,039 565 1,492 365
(Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investments (150) (158) (184) (219)
Changes in revaluation reserve real estate held for own use 3 1 3 -
Changes in cash flow hedging reserve 443 84 113 (3)
Movement in foreign currency translation and net foreign investment hedging reserve 769 (295) 464 (1,183)
Equity movements of associates 2 1 19 (7)
Aggregate tax effect of items recognized in other comprehensive income (429) (156) (416) (56)
Other (7) (7) (5) (6)
Other comprehensive income for the period 1,670 35 1,486 (1,109)
Total comprehensive income 1,924 439 2,261 (378)
Total comprehensive income attributable to:
Equity holders of AEGON N.V. 1,925 439 2,262 (378)
Non-controlling interests (1) - (1) -

Unaudited

AEGON


CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION

June 30, 2012 Dec. 31, 2011
EUR millions Notes
ASSETS
Intangible assets 12 3,213 3,285
Investments 13 147,065 144,079
Investments for account of policyholders 14 151,633 142,529
Derivatives 15 20,072 15,504
Investments in associates 791 742
Reinsurance assets 16 12,661 11,517
Deferred expenses and rebates 17 11,879 11,633
Other assets and receivables 7,931 8,184
Cash and cash equivalents 8,737 8,104
Total assets 363,982 345,577
EQUITY AND LIABILITIES
Shareholders' equity 23,018 21,000
Other equity instruments 19 5,002 4,720
Issued capital and reserves attributable to equity holders of AEGON N.V. 28,020 25,720
Non-controlling interests 13 14
Group equity 28,033 25,734
Trust pass-through securities 163 159
Subordinated borrowings 20 61 18
Insurance contracts 108,008 105,175
Insurance contracts for account of policyholders 78,037 73,425
Investment contracts 19,790 20,847
Investment contracts for account of policyholders 75,668 71,433
Derivatives 15 16,182 12,728
Borrowings 21 11,065 10,141
Other liabilities 26,975 25,917
Total liabilities 335,949 319,843
Total equity and liabilities 363,982 345,577

Local knowledge. Global power.

Unaudited


CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

EUR millions Share capital¹ Retained earnings Revaluation reserves Other reserves Convertible core capital securities Other equity instruments Issued capital and reserves² Non-controlling interests Total
Six months ended June 30, 2012
At beginning of year 9,097 9,403 3,464 (964) - 4,720 25,720 14 25,734
Net income recognized in the income statement - 775 - - - - 775 - 775
Other comprehensive income:
Gains / (losses) on revaluation of available-for-sale investments - - 1,492 - - - 1,492 - 1,492
(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments - - (184) - - - (184) - (184)
Changes in revaluation reserve real estate held for own use - - 3 - - - 3 - 3
Changes in cash flow hedging reserve - - 113 - - - 113 - 113
Movement in foreign currency translation and net foreign investment hedging reserves - - - 464 - - 464 - 464
Equity movements of associates - - - 19 - - 19 - 19
Aggregate tax effect of items recognized in other comprehensive income - - (398) (18) - - (416) - (416)
Transfer from / to other headings - (20) 20 - - - - - -
Other - (4) - - - - (4) (1) (5)
Total other comprehensive income - (24) 1,046 465 - - 1,487 (1) 1,486
Total comprehensive income/ (loss) for 2012 - 751 1,046 465 - - 2,262 (1) 2,261
Treasury shares - 2 - - - - 2 - 2
Dividends paid on common shares - (79) - - - - (79) - (79)
Preferred dividend - (59) - - - - (59) - (59)
Issuance of non-cumulative subordinated loans - - - - - 271 271 - 271
Coupons on non-cumulative subordinated notes - (10) - - - - (10) - (10)
Cost of issuance of non-cumulative subordinated notes (net of tax) - (10) - - - - (10) - (10)
Coupons on perpetual securities - (88) - - - - (88) - (88)
Share options and incentive plans - - - - - 11 11 - 11
At end of period 9,097 9,910 4,510 (499) - 5,002 28,020 13 28,033
Six months ended June 30, 2011
At beginning of year 8,184 9,529 958 (1,343) 1,500 4,704 23,532 11 23,543
Net income recognized in the income statement - 730 - - - - 730 1 731
Other comprehensive income:
Gains / (losses) on revaluation of available-for-sale investments - - 365 - - - 365 - 365
(Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments - - (219) - - - (219) - (219)
Changes in revaluation reserve real estate held for own use - - (3) - - - (3) - (3)
Movement in foreign currency translation and net foreign investment hedging reserves - - - (1,183) - - (1,183) - (1,183)
Equity movements of associates - - - (7) - - (7) - (7)
Aggregate tax effect of items recognized in other comprehensive income - - (112) 56 - - (56) - (56)
Other - (5) - - - - (5) (1) (6)
Total other comprehensive income - (5) 31 (1,134) - - (1,108) (1) (1,109)
Total comprehensive income / (loss) for 2011 - 725 31 (1,134) - - (378) - (378)
Shares issued 913 - - - - - 913 - 913
Cost of issuance of shares (net of tax) - (14) - - - - (14) - (14)
Preferred dividend - (59) - - - - (59) - (59)
Coupons on perpetual securities - (87) - - - - (87) - (87)
Repurchase of convertible core capital securities - - - - (1,500) - (1,500) - (1,500)
Coupons and premium on convertible core capital securities - (750) - - - - (750) - (750)
Share options and incentive plans - - - - - 7 7 - 7
At end of period 9,097 9,344 989 (2,477) - 4,711 21,664 11 21,675

¹ For a breakdown of share capital please refer to note 18.
² Issued capital and reserves attributable to equity holders of AEGON N.V.

Unaudited

AEGON


CONDENSED CONSOLIDATED CASH FLOW STATEMENT

EUR millions YTD 2012 YTD 2011
Cash flow from operating activities (228) (345)
Purchases and disposals of intangible assets (15) (7)
Purchases and disposals of equipment and other assets (28) (25)
Purchases, disposals and dividends of subsidiaries and associates (5) (7)
Cash flow from investing activities (48) (39)
Issuance of share capital - 913
Dividends paid (138) (59)
Issuances, repurchases and coupons of convertible core capital securities - (2,250)
Issuances, repurchases and coupons of perpetuals (117) (117)
Issuances, repurchases and coupons of non cumulative subordinated notes 257 -
Issuances and repayments of borrowings 1,050 1,149
Cash flow from financing activities 1,052 (364)
Net increase / (decrease) in cash and cash equivalents 776 (748)
Net cash and cash equivalents at January 1 7,826 5,174
Effects of changes in foreign exchange rates 52 (46)
Net cash and cash equivalents at end of period 8,654 4,380
June 30, 2012 June 30, 2011
Cash and cash equivalents 8,737 4,450
Bank overdrafts (83) (70)
Net cash and cash equivalents 8,654 4,380

Local knowledge. Global power.

Unaudited


Notes to the condensed consolidated interim financial statements

Amounts in EUR millions, unless otherwise stated

1. Basis of presentation

The condensed consolidated interim financial statements as at, and for the second quarter ended, June 30, 2012, have been prepared in accordance with IAS 34 'Interim financial reporting' as adopted by the European Union (EU) as issued by the International Accounting Standards Board (IASB). They do not include all of the information required for a full set of financial statements prepared in accordance with International Financial Reporting Standards (IFRS) and should therefore be read together with the 2011 consolidated financial statements of AEGON N.V. as included in AEGON's Annual Report for 2011. AEGON's Annual Report for 2011 is available on its website (www.aegon.com).

The condensed consolidated interim financial statements have been prepared in accordance with the historical cost convention as modified by the revaluation of investment properties and those financial instruments (including derivatives) and financial liabilities that have been measured at fair value. The condensed consolidated interim financial statements as at, and for the second quarter ended, June 30, 2012, were approved by the Executive Board on August 8, 2012.

The published figures in these condensed consolidated interim financial statements are unaudited.

2. Significant accounting policies

All accounting policies and methods of computation applied in the condensed consolidated interim financial statements are the same as those applied in the 2011 consolidated financial statements, which were prepared in accordance with IFRS as issued by the International Accounting Standards Board as adopted by the European Union, except for the following accounting policy for compound instruments:

  • Non-cumulative subordinated notes, issued on February 7, 2012, are identified as a compound instrument due to the nature of this financial instrument. For these non-cumulative subordinated notes, issued in US dollars, AEGON has an unconditional right to avoid delivering cash or another financial asset to settle the coupon payments. The redemption of the principal is however not at the discretion of AEGON and therefore AEGON has a contractual obligation to settle the redemption in cash or another financial asset or through the exchange of financial assets and liabilities at potentially unfavorable conditions for AEGON. Compound instruments are separated into liability components and equity components. The liability component for the non-cumulative subordinated notes is equal to the present value of the redemption amount and subsequently carried at amortized cost using the effective interest rate method. The liability component is derecognized when the Group's obligation under the contract expires, is discharged or is cancelled. The equity component is assigned the residual amount after deducting the liability component from the fair value of the instrument as a whole. The equity component in US dollars is translated into euro using the historical transaction exchange rates.

Incremental external costs that are directly attributable to the issuing or buying back of the non-cumulative subordinated notes are recognized in either equity or income statement proportionately to the equity component and liability component, net of tax.

Coupon payments and other distributions to holders of the non-cumulative subordinated notes are recognized directly in equity, net of tax. A liability for non-cumulative dividends payable is not recognized until the coupon has been declared and approved.

Unaudited

AEGON

page 7


The following standards, interpretations, amendments to standards and interpretations became effective in 2012:

  • Amendment to IFRS 1 First time adoption - Severe Hyperinflation and Removal of Fixed Dates for First Time Adopters.
  • Amendment to IFRS 7 Disclosures - Transfers of Financial Assets.
  • IAS 12 Income Taxes - Recovery of Tax Assets.

None of these new or revised standards and interpretations had a significant effect on the condensed consolidated interim financial statements for the period ended June 30, 2012.

Taxes on income for the first six months of 2012 are accrued using the tax rate that would be applicable to expected total annual earnings.

Critical accounting estimates

Certain amounts recorded in the condensed consolidated interim financial statements reflect estimates and assumptions made by management. Actual results may differ from the estimates made.

Exchange rates

Assets and liabilities are translated at the closing rates on the balance sheet date. Income, expenses and capital transactions (such as dividends) are translated at average exchange rates or at the prevailing rates on the transaction date, if more appropriate. The following exchange rates are applied for the condensed consolidated interim financial statements:

Closing exchange rates USD GBP
June 30, 2012 1 EUR 1.2691 0.8091
December 31, 2011 1 EUR 1.2982 0.8353
Weighted average exchange rates
--- --- --- --- ---
USD GBP
First six months 2012 1 EUR 1.2962
First six months 2011 1 EUR 1.4025

Local knowledge. Global power.

Unaudited


3. Segment information

3.1 Income statement

EUR millions Americas The Netherlands United Kingdom New Markets Holding and other activities Eliminations Segment Total Associates eliminations Consolidated
Three months ended June 30, 2012
Underlying earnings before tax geographically 339 71 25 64 (56) - 443 (1) 442
Fair value items (79) 153 (1) (12) 40 - 101 - 101
Realized gains / (losses) on investments 54 (6) 34 3 - - 85 - 85
Impairment charges (57) (3) - - - 2 (58) - (58)
Impairment reversals 18 - - - - (2) 16 - 16
Other income / (charges) (1) (266) 13 - - - (254) - (254)
Run-off businesses 6 - - - - - 6 - 6
Income before tax 280 (51) 71 55 (16) - 339 (1) 338
Income tax (expense) / benefit (65) 23 (22) (18) (3) - (85) 1 (84)
Net income 215 (28) 49 37 (19) - 254 - 254
Inter-segment underlying earnings (47) (21) (16) 71 13
Revenues
Life insurance gross premiums 1,615 410 1,572 348 - (16) 3,929 (41) 3,888
Accident and health insurance 456 43 - 42 1 (1) 541 - 541
General insurance - 134 - 34 - - 168 - 168
Total gross premiums 2,071 587 1,572 424 1 (17) 4,638 (41) 4,597
Investment income 930 558 627 89 100 (101) 2,203 (3) 2,200
Fee and commission income 294 80 35 129 - (69) 469 - 469
Other revenues 1 - - - 2 - 3 - 3
Total revenues 3,296 1,225 2,234 642 103 (187) 7,313 (44) 7,269
Inter-segment revenues 9 - - 78 100
EUR millions Americas The Netherlands United Kingdom New Markets Holding and other activities Eliminations Segment Total Associates eliminations Consolidated
--- --- --- --- --- --- --- --- --- ---
Three months ended June 30, 2011
Underlying earnings before tax geographically 314 74 10 70 (68) 1 401 (4) 397
Fair value items (52) 2 - (3) 30 - (23) - (23)
Realized gains / (losses) on investments 50 142 11 1 - - 204 - 204
Impairment charges (69) (3) (40) (4) - - (116) 1 (115)
Impairment reversals 16 - - - - - 16 - 16
Other income / (charges) (3) (11) 1 (3) - - (16) - (16)
Run-off businesses 10 - - - - - 10 - 10
Income before tax 266 204 (18) 61 (38) 1 476 (3) 473
Income tax (expense) / benefit (36) (35) - (15) 14 - (72) 3 (69)
Net income 230 169 (18) 46 (24) 1 404 - 404
Inter-segment underlying earnings (39) (10) (17) 61 5
Revenues
Life insurance gross premiums 1,455 483 1,648 347 - (14) 3,919 (69) 3,850
Accident and health insurance 410 40 - 38 - - 488 (1) 487
General insurance - 127 - 37 - - 164 - 164
Total gross premiums 1,865 650 1,648 422 - (14) 4,571 (70) 4,501
Investment income 879 549 609 80 83 (82) 2,118 (19) 2,099
Fee and commission income 253 79 36 118 - (58) 428 - 428
Other revenues 1 - - - 1 - 2 - 2
Total revenues 2,998 1,278 2,293 620 84 (154) 7,119 (89) 7,030
Inter-segment revenues 8 - 1 65 80

As of the first quarter of 2012, AEGON has revised its financial reporting to reflect changes in its organization. Businesses in Asia, which were previously managed by AEGON Americas, are included in the Asia line of business within the "New Markets" segment. For the full year 2011, the underlying earnings before tax generated by the Asian operations totaling EUR 37 million were previously reported under the "Americas" segment.

Unaudited

AEGON


EUR millions Americas The Netherlands United Kingdom New Markets Holding and other activities Eliminations Segment Total Associates eliminations Consolidated
Six months ended June 30, 2012
Underlying earnings before tax geographically 631 150 54 152 (117) (2) 868 (4) 864
Fair value items (15) 195 (3) (5) 85 - 257 - 257
Realized gains / (losses) on investments 63 28 34 5 - - 130 - 130
Impairment charges (93) (6) - (4) (4) 2 (105) - (105)
Impairment reversals 24 - - - - (2) 22 - 22
Other income / (charges) (2) (269) 19 (18) (1) - (271) - (271)
Run-off businesses 4 - - - - - 4 - 4
Income before tax 612 98 104 130 (37) (2) 905 (4) 901
Income tax (expense) / benefit (118) 15 (9) (45) 27 - (130) 4 (126)
Net income 494 113 95 85 (10) (2) 775 - 775
Inter-segment underlying earnings (93) (33) (32) 142 16
Revenues
Life insurance gross premiums 3,196 2,182 2,987 756 - (34) 9,087 (134) 8,953
Accident and health insurance 900 152 - 104 2 (2) 1,156 - 1,156
General insurance - 268 - 71 - - 339 - 339
Total gross premiums 4,096 2,602 2,987 931 2 (36) 10,582 (134) 10,448
Investment income 1,820 1,110 1,189 175 189 (188) 4,295 (19) 4,276
Fee and commission income 579 166 66 257 - (134) 934 - 934
Other revenues 1 - - 1 3 - 5 - 5
Total revenues 6,496 3,878 4,242 1,364 194 (358) 15,816 (153) 15,663
Inter-segment revenues 16 - 1 154 187
EUR millions Americas The Netherlands United Kingdom New Markets Holding and other activities Eliminations Segment Total Associates eliminations Consolidated
--- --- --- --- --- --- --- --- --- ---
Six months ended June 30, 2011
Underlying earnings before tax geographically 650 155 22 138 (150) - 815 (8) 807
Fair value items (64) (58) (1) (3) 18 - (108) - (108)
Realized gains / (losses) on investments 74 177 40 4 - - 295 - 295
Impairment charges (152) (6) (40) (6) - - (204) 1 (203)
Impairment reversals 41 1 - - - - 42 - 42
Other income / (charges) (3) (19) (5) 8 - - (19) - (19)
Run-off businesses 32 - - - - - 32 - 32
Income before tax 578 250 16 141 (132) - 853 (7) 846
Income tax (expense) / benefit (92) (42) 20 (46) 38 - (122) 7 (115)
Net income 486 208 36 95 (94) - 731 - 731
Inter-segment underlying earnings (79) (20) (34) 125 8
Revenues
Life insurance gross premiums 2,977 2,354 3,510 782 - (25) 9,598 (225) 9,373
Accident and health insurance 823 149 - 97 - - 1,069 (1) 1,068
General insurance - 259 - 78 - - 337 - 337
Total gross premiums 3,800 2,762 3,510 957 - (25) 11,004 (226) 10,778
Investment income 1,814 1,069 1,208 155 166 (163) 4,249 (39) 4,210
Fee and commission income 527 174 73 236 - (122) 888 - 888
Other revenues 1 - - 1 2 - 4 - 4
Total revenues 6,142 4,005 4,791 1,349 168 (310) 16,145 (265) 15,880
Inter-segment revenues 14 1 1 135 159

Local knowledge. Global power.

Unaudited


Non-IFRS measures

This report includes the non-IFRS financial measure: underlying earnings before tax. The reconciliation of this measure to the most comparable IFRS measure is presented in the tables in this note. This non-IFRS measure is calculated by consolidating on a proportionate basis the revenues and expenses of AEGON's associated companies in Spain, India, Brazil and Mexico. AEGON believes that its non-IFRS measure provides meaningful information about the underlying operating results of AEGON's business including insight into the financial measures that senior management uses in managing the business.

AEGON's senior management is compensated based in part on AEGON's results against targets using the non-IFRS measure presented here. While many other insurers in AEGON's peer group present substantially similar non-IFRS measures, the non-IFRS measure presented in this document may nevertheless differ from the non-IFRS measures presented by other insurers. There is no standardized meaning to these measures under IFRS or any other recognized set of accounting standards and readers are cautioned to consider carefully the different ways in which AEGON and its peers present similar information before comparing them.

AEGON believes the non-IFRS measure shown herein, when read together with AEGON's reported IFRS financial statements, provides meaningful supplemental information for the investing public to evaluate AEGON's business after eliminating the impact of current IFRS accounting policies for financial instruments and insurance contracts, which embed a number of accounting policy alternatives that companies may select in presenting their results (i.e. companies can use different local GAAPs to measure the insurance contract liability) and that can make the comparability from period to period difficult.

Underlying earnings

Certain assets held by AEGON Americas, AEGON The Netherlands and AEGON UK are carried at fair value and managed on a total return basis, with no offsetting changes in the valuation of related liabilities. These include assets such as investments in hedge funds, private equities, real estate limited partnerships, convertible bonds and structured products. Underlying earnings exclude any over- or underperformance compared to management's long-term expected return on assets.

Based on current holdings and asset returns, the long-term expected return on an annual basis is 8-10%, depending on asset class, including cash income and market value changes. The expected earnings from these asset classes are net of deferred policy acquisition costs (DPAC) where applicable.

In addition, certain products offered by AEGON Americas contain guarantees and are reported on a fair value basis, including the segregated funds offered by AEGON Canada and the total return annuities and guarantees on variable annuities of AEGON USA. The earnings on these products are impacted by movements in equity markets and risk-free interest rates. Short-term developments in the financial markets may therefore cause volatility in earnings. Included in underlying earnings is a long-term expected return on these products and excluded is any over- or underperformance compared to management's expected return. The fair value movements of certain guarantees and the fair value change of derivatives that hedge certain risks on these guarantees of AEGON The Netherlands and Variable Annuities Europe (included in New Markets) are excluded from underlying earnings, and the long-term expected return for these guarantees is set at zero.

Holding and other activities include certain issued bonds that are held at fair value through profit or loss (FVTPL). The interest rate risk on these bonds is hedged using swaps. The fair value movement resulting from changes in AEGON's credit spread used in the valuation of these bonds are excluded from underlying earnings and reported under fair value items.

Unaudited

AEGON


page 12
Local knowledge. Global power.
Unaudited

Fair value items

Fair value items include the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in underlying earnings. Changes to these long-term return assumptions are also included in the fair value items.

In addition, hedge ineffectiveness on hedge transactions, fair value changes on economic hedges without natural offset in earnings and for which no hedge accounting is applied and fair value movements on real estate are included under fair value items.

Realized gains or losses on investments

Includes realized gains and losses on available-for-sale investments, mortgage loans and loan portfolios.

Impairment charges / reversals

Includes impairments and reversals on available-for-sale debt securities and impairments on shares including the effect of deferred policyholder acquisition costs, mortgage loans and loan portfolios on amortized cost and associates respectively.

Other income or charges

Other income or charges is used to report any items which cannot be directly allocated to a specific line of business. Also items that are outside the normal course of business are reported under this heading.

Other charges include restructuring charges that are considered other charges for segment reporting purposes because they are outside the normal course of business. In the condensed consolidated income statement, these charges are included in operating expenses.

Run-off businesses

Includes underlying results of business units where management has decided to exit the market and to run off the existing block of business. Currently, this line includes the run-off of the institutional spread-based business, structured settlements blocks of business, Bank-Owned and Corporate-Owned Life Insurance (BOLI/COLI) business and life reinsurance business in the United States. AEGON has other blocks of business for which sales have been discontinued and of which the earnings are included in underlying earnings.

Share in earnings of associates

Earnings from AEGON's associates in insurance companies in Spain, India, Brazil and Mexico are reported on an underlying earnings basis. Other associates are included on a net income basis.


3.2 Investments geographically

Americas USD United Kingdom GBP At June 30, 2012 Americas The Netherlands United Kingdom amounts in million EUR (unless otherwise stated) Total EUR
New Markets Holding & other activities Eliminations
Investments
1,688 39 Shares 1,330 411 49 69 6 (2) 1,863
84,231 8,395 Debt securities 66,371 17,888 10,375 4,271 - - 98,905
12,481 6 Loans 9,834 19,648 7 692 - - 30,181
15,338 20 Other financial assets 12,086 311 25 37 802 - 13,261
1,101 - Investments in real estate 867 1,988 - - - - 2,855
114,839 8,460 Investments general account 90,488 40,246 10,456 5,069 808 (2) 147,065
- 22,075 Shares - 7,950 27,283 3,575 - (5) 38,803
- 9,692 Debt securities - 16,412 11,979 390 - - 28,781
84,548 7,654 Separate accounts and investment funds 66,621 - 9,460 1,160 - - 77,241
- 2,845 Other financial assets - 463 3,516 1,710 - - 5,689
- 905 Investments in real estate - - 1,119 - - - 1,119
84,548 43,171 Investments for account of policyholders 66,621 24,825 53,357 6,835 - (5) 151,633
199,387 51,631 Investments on balance sheet 157,109 65,071 63,813 11,904 808 (7) 298,698
125,587 - Off balance sheet investments third parties 98,958 - - 54,332 - - 153,290
324,974 51,631 Total revenue generating investments 256,067 65,071 63,813 66,236 808 (7) 451,988
Investments
95,384 8,399 Available-for-sale 75,159 18,369 10,381 4,115 25 - 108,049
12,481 6 Loans 9,834 19,648 7 692 - - 30,181
- - Held-to-maturity - - - 172 - - 172
90,421 42,321 Financial assets at fair value through profit or loss 71,249 25,066 52,306 6,925 783 (7) 156,322
1,101 905 Investments in real estate 867 1,988 1,119 - - - 3,974
199,387 51,631 Total investments on balance sheet 157,109 65,071 63,813 11,904 808 (7) 298,698
115 7 Investments in associates 91 51 9 635 5 - 791
33,867 6,076 Other assets 26,686 25,216 7,509 3,915 37,985 (36,818) 64,493
233,369 57,714 Consolidated total assets 183,886 90,338 71,331 16,454 38,798 (36,825) 363,982
Americas USD United Kingdom GBP At December 31, 2011 Americas The Netherlands United Kingdom amounts in million EUR (unless otherwise stated) Total EUR
--- --- --- --- --- --- --- --- --- ---
New Markets Holding & other activities Eliminations
Investments
1,570 45 Shares 1,209 505 54 60 11 (2) 1,837
84,192 8,261 Debt securities 64,853 17,640 9,890 4,036 - - 96,419
13,319 7 Loans 10,260 18,825 8 643 - - 29,736
16,196 - Other financial assets 12,476 40 - 43 744 - 13,303
1,006 - Investments in real estate 775 2,009 - - - - 2,784
116,283 8,313 Investments general account 89,573 39,019 9,952 4,782 755 (2) 144,079
- 21,755 Shares - 7,608 26,045 3,459 - (4) 37,108
- 10,003 Debt securities - 15,124 11,975 277 - - 27,376
80,137 7,095 Separate accounts and investment funds 61,729 - 8,495 1,060 - - 71,284
- 2,940 Other financial assets - 491 3,519 1,619 - - 5,629
- 946 Investments in real estate - - 1,132 - - - 1,132
80,137 42,739 Investments for account of policyholders 61,729 23,223 51,166 6,415 - (4) 142,529
196,420 51,052 Investments on balance sheet 151,302 62,242 61,118 11,197 755 (6) 286,608
119,371 - Off balance sheet investments third parties 91,951 - - 44,959 - - 136,910
315,791 51,052 Total revenue generating investments 243,253 62,242 61,118 56,156 755 (6) 423,518
Investments
96,145 8,266 Available-for-sale 74,060 18,016 9,896 3,861 27 - 105,860
13,319 7 Loans 10,260 18,825 8 643 - - 29,736
- - Held-to-maturity - - - 168 - - 168
85,950 41,833 Financial assets at fair value through profit or loss 66,207 23,392 50,082 6,525 728 (6) 146,928
1,006 946 Investments in real estate 775 2,009 1,132 - - - 3,916
196,420 51,052 Total investments on balance sheet 151,302 62,242 61,118 11,197 755 (6) 286,608
100 7 Investments in associates 77 52 9 600 4 - 742
33,562 5,919 Other assets 25,852 19,403 7,086 3,789 35,878 (33,781) 58,227
230,082 56,978 Consolidated total assets 177,231 81,697 68,213 15,586 36,637 (33,787) 345,577

Unaudited

EAGON


4. Premium income and premium to reinsurers

EUR millions Q2 2012 Q2 2011 YTD 2012 YTD 2011
Gross
Life 3,888 3,850 8,953 9,373
Non-Life 709 651 1,495 1,405
Total 4,597 4,501 10,448 10,778
Reinsurance
Life 805 380 1,630 742
Non-Life 105 87 205 168
Total 910 467 1,835 910

Reinsurance premiums increased compared to 2011 mainly as a result of the increased external reinsurance life premiums following the divestment of the life reinsurance business, Transamerica Reinsurance, to SCOR, completed on August 9, 2011. Premiums paid to reinsurers are reported as part of Claims and benefits (note 9).

5. Investment income

EUR millions Q2 2012 Q2 2011 YTD 2012 YTD 2011
Interest income 1,927 1,785 3,739 3,622
Dividend income 234 273 459 501
Rental income 39 41 78 87
Total investment income 2,200 2,099 4,276 4,210
Investment income related to general account 1,514 1,432 2,973 2,903
Investment income for account of policyholders 686 667 1,303 1,307
Total 2,200 2,099 4,276 4,210

6. Income from reinsurance ceded

The increase in Income from reinsurance ceded is mainly the result of the increased income from external reinsurance following the divestment of the life reinsurance business, Transamerica Reinsurance, to SCOR, completed on August 9, 2011.

7. Results from financial transactions

EUR millions Q2 2012 Q2 2011 YTD 2012 YTD 2011
Net fair value change of general account financial investments at FVTPL other than derivatives (17) 30 246 157
Realized gains and (losses) on financial investments 191 277 246 381
Gains and (losses) on investments in real estate (31) (15) (56) (26)
Net fair value change of derivatives 263 (78) 393 (601)
Net fair value change on for account of policyholder financial assets at FVTPL (2,368) 728 4,799 2,138
Net fair value change on investments in real estate for account of policyholders (11) 5 (19) 11
Net foreign currency gains and (losses) 5 (1) 12 (9)
Net fair value change on borrowings and other financial liabilities 18 (18) (6) (10)
Realized gains and (losses) on repurchased debt 6 4 6 4
Total (1,944) 932 5,621 2,045

Net fair value changes on for account of policyholder financial assets at fair value through profit and loss are offset by amounts in Claims and benefits reported in the Benefits and expenses line (note 9).

Local knowledge. Global power.

Unaudited


Unaudited
AEGON
page 15

8. Other income

Other income for the six months ended June 30, 2011 mainly relates to a benefit related to a settlement of legal claims.

9. Benefits and expenses

EUR millions Q2 2012 Q2 2011 YTD 2012 YTD 2011
Claims and benefits 5,056 6,945 20,550 16,013
Employee expenses 529 517 1,033 1,054
Administration expenses 272 313 534 597
Deferred expenses (370) (371) (737) (758)
Amortization charges 411 355 682 712
Total 5,898 7,759 22,062 17,618

Claims and benefits reflects the claims and benefits paid to policyholders, including claims and benefits in excess of account value for products for which deposit accounting is applied and the change in valuation of liabilities for insurance and investment contracts. In addition, Claims and benefits includes commissions and expenses, as well as premium paid to reinsurers. Claims and benefits fluctuates mainly as a result of changes in technical provisions resulting from fair value changes on for account of policyholder financial assets included in Results from financial transactions (note 7).

In Q2 2012, AEGON increased the technical provisions related to unit-linked insurance policies with EUR 265 million. This addition to the technical provisions is included in Claims and benefits. Refer to note 22 Commitments and contingencies for more details.

10. Impairment charges / (reversals)

EUR millions Q2 2012 Q2 2011 YTD 2012 YTD 2011
Impairment charges / (reversals) comprise:
Impairment charges on financial assets, excluding receivables 1 66 121 116 209
Impairment reversals on financial assets, excluding receivables 1 (16) (16) (22) (42)
Impairment charges / (reversals) on non-financial assets and receivables 2 1 4 3
Total 52 106 98 170
Impairment charges on financial assets, excluding receivables, from:
Shares - 1 4 3
Debt securities and money market instruments 55 115 86 185
Loans 11 6 25 15
Other - (1) 1 6
Total 66 121 116 209
Impairment reversals on financial assets, excluding receivables, from:
Debt securities and money market instruments (16) (14) (17) (38)
Loans - (2) (5) (4)
Total (16) (16) (22) (42)

1 Impairment charges / (reversals) on financial assets, excluding receivables, are excluded from underlying earnings before tax for segment reporting (refer to note 3).

11. Other charges

Other charges for the six months ended June 30, 2012 and 2011, consist mainly of the annual bank tax charge in Hungary.


12. Intangible assets

EUR millions June 30, 2012 Dec. 31, 2011
Goodwill 758 753
VOBA 1,997 2,086
Future servicing rights 401 397
Software 46 36
Other 11 13
Total intangible assets 3,213 3,285

The increase in goodwill is attributable to foreign currency effects. The decrease in value of business acquired (VOBA) is mainly attributable to regular amortization and the impact of shadow accounting partly offset by foreign currency effects.

13. Investments

EUR millions June 30, 2012 Dec. 31, 2011
Available-for-sale (AFS) 108,049 105,860
Loans 30,181 29,736
Held-to-maturity (HTM) 172 168
Financial assets at fair value through profit or loss (FVTPL) 5,808 5,531
Financial assets, excluding derivatives 144,210 141,295
Investments in real estate 2,855 2,784
Total investments for general account 147,065 144,079
Total financial assets, excluding derivatives AFS FVTPL HTM Loans
Shares 900 963 - -
Debt securities 97,099 1,634 172 -
Money market and other short term investments 8,796 1,159 - -
Mortgages - - - 26,552
Private loans - - - 1,063
Deposits with financial institutions - - - 190
Policy loans - - - 2,207
Receivables out of share lease agreements - - - 11
Other 1,254 2,052 - 158
June 30, 2012 108,049 5,808 172 30,181
AFS FVTPL HTM Loans
Shares 869 968 - -
Debt securities 94,722 1,529 168 -
Money market and other short term investments 9,382 1,090 - -
Mortgages - - - 26,012
Private loans - - - 927
Deposits with financial institutions - - - 452
Policy loans - - - 2,180
Receivables out of share lease agreements - - - 19
Other 887 1,944 - 146
December 31, 2011 105,860 5,531 168 29,736

page 16
Local knowledge. Global power.
Unaudited


European peripheral countries exposure

AEGON's exposure to the central governments of the European peripheral countries of Portugal, Italy, Ireland, Greece and Spain amounts to EUR 1,011 million (December 31, 2011: EUR 1,112 million), of which EUR 769 million is included in the available-for-sale investments. The remainder of the exposure, amounting to EUR 242 million (December 31, 2011: EUR 214 million), relates to AEGON's proportionate share in the investments of its associate CAM AEGON Holding Financiero (Spain).

The following table provides the amortized cost and fair value of AEGON's exposure to European peripheral countries.

EUR millions June 30, 2012 Dec. 31, 2011
Debt security exposure to:
Central Government Banks RMBS Corporates and other Total Total
Amortized cost Fair value Amortized cost Fair value Amortized cost Fair value Amortized cost Fair value Amortized cost Fair value Amortized cost Fair value
Portugal 10 7 26 24 40 32 96 85 172 149 202 157
Italy 58 54 184 169 48 46 642 563 932 832 1,095 949
Ireland 25 24 1 1 177 134 362 394 565 553 582 584
Greece - - - - 5 3 22 24 27 27 34 32
Spain 918 818 410 339 708 609 816 742 2,852 2,507 3,194 2,965
Total 1,011 903 621 533 978 824 1,938 1,808 4,548 4,068 5,107 4,687

14. Investments for account of policyholders

EUR millions June 30, 2012 Dec. 31, 2011
Shares 38,803 37,108
Debt securities 28,781 27,376
Money market and short-term investments 2,212 2,283
Deposits with financial institutions 2,980 2,813
Separate accounts and unconsolidated investment funds 77,241 71,284
Other 497 533
Total investments for account of policyholders at fair value through profit or loss, excluding derivatives 150,514 141,397
Investment in real estate 1,119 1,132
Total investments for account of policyholders 151,633 142,529

15. Derivatives

In the first quarter of 2012, AEGON The Netherlands entered into a derivative to partially hedge its longevity risk. The derivative, with a notional amount of EUR 12 billion, becomes in the money if - over 20 years - realized mortality rates are more than 7.5% lower than pre-defined mortality tables. The derivative is measured at fair value through profit or loss in accordance with IAS 39. The value of the longevity derivative is calculated using an internal model as there is no active market for this type of derivative.

The movements in derivative balances mainly result from changes in market conditions.

16. Reinsurance assets

AEGON USA reinsured approximately EUR 1.2 billion of fixed annuities on a quota share basis resulting in an increase of reinsurance assets in the second quarter of 2012.

Unaudited

AEGON


17. Deferred expenses and rebates

EUR millions June 30, 2012 Dec. 31, 2011
DPAC for insurance contracts and investment contracts with discretionary participation features 10,676 10,486
Deferred cost of reinsurance 606 541
Deferred transaction costs for investment management services 417 405
Unamortized interest rate rebates 180 201
Total deferred expenses and rebates 11,879 11,633

18. Share capital

EUR millions June 30, 2012 Dec. 31, 2011
Share capital - par value 314 310
Share premium 8,783 8,787
Total share capital 9,097 9,097
Share capital - par value
Balance at January 1 310 278
Issuance - 32
Stock dividend 4 -
Balance 314 310
Share premium
Balance at January 1 8,787 7,906
Issuance - 881
Stock dividend (4) -
Balance 8,783 8,787

19. Other equity instruments

On February 7, 2012, AEGON issued USD 525 million in aggregate principal amount of 8.00% non-cumulative subordinated notes, due 2042, in an underwritten public offering in the United States registered with the U.S. Securities and Exchange Commission. The subordinated notes bear interest at a fixed rate of 8.00% and will not be cumulative and are priced at 100% of their principal amount.

The securities are subordinated and rank senior to the junior perpetual capital securities, equally with the perpetual cumulative subordinated bonds junior to all other liabilities. The conditions of the securities contain certain provisions for optional and required cancellation of interest payments. The securities have a stated maturity of 30 years, however AEGON has the right to call the securities for redemption at par for the first time on the coupon date in 2017, or on any coupon payment date thereafter.

The interest rate exposure on substantially all of these securities has been swapped to an EURIBOR based interest rate.

Local knowledge. Global power.
Unaudited


These notes are recognized as a compound instrument due to the nature of this financial instrument. Compound instruments are separated into equity components and liability components. At June 30, 2012 the equity component amount to EUR 271 million, subordinated borrowings amounts to EUR 42 million and a deferred tax liability (included in Other liabilities) amounts to EUR 93 million. Refer to note 20 for the component classified as Subordinated borrowings. The proceeds from the issuance of the subordinated notes are used for general corporate purposes.

20. Subordinated borrowings

Subordinated borrowings include a liability of EUR 42 million relating to the non-cumulative subordinated notes issued on February 7, 2012. This liability component of the non-cumulative subordinated notes is related to the redemption amount. For further information on the non-cumulative subordinated notes refer to note 19.

21. Borrowings

EUR millions June 30, 2012 Dec. 31, 2011
Debentures and other loans 10,528 9,199
Commercial paper 437 646
Short term deposits 17 18
Bank overdrafts 83 278
Total borrowings 11,065 10,141

Debentures and other loans

On May 23, 2012, AEGON USA sold asset backed securities (ABS) to institutional investors amounting to EUR 230 million. These securities consist of three tranches:

  • USD 227.5 million of class A-1 notes with a legal final maturity date of April 15, 2023 and priced at 99.652 with a coupon of three month Libor plus 1.30%.
  • USD 39.65 million of class A-2 notes with a legal final maturity date of April 15, 2023 and priced at 99.267 with a coupon of three month Libor plus 2.50%.
  • USD 24.5 million of class B notes with a legal final maturity date of April 15, 2023 and priced at 90.289 with a coupon of three month Libor plus 3.00%.

The net proceeds were used to finance a part of the existing bank loan portfolio of AEGON USA.

On May 8, 2012, AEGON The Netherlands sold class A residential mortgage backed securities (RMBS) to a broad group of institutional investors amounting to EUR 685 million. These securities consist of two tranches:

  • USD 600 million of class A1 notes with an expected weighted average life of 3 years and priced at par with a coupon of three month Libor plus 1.55%.
  • EUR 212 million of class A1 notes with an expected weighted average life of 3 years and priced at par with a coupon of three month Euribor plus 1.35%.

The securities were issued under the Dutch SAECURE program. The net proceeds were used to finance a part of the existing Dutch mortgage portfolio of AEGON The Netherlands.

On April 29, 2012 AEGON redeemed a EUR 1.0 billion senior loan, which matured.

On March 1, 2012, AEGON The Netherlands borrowed EUR 1.5 billion from the European Central Bank, under its Long Term Refinancing Operation (LTRO) program. The borrowing has a 3 year term and bears 1% interest per annum. The borrowing is fully collateralized. The funds will be mainly used to fund the mortgage loan production of AEGON The Netherlands.

Unaudited

AEGON


Included in Debentures and other loans is EUR 1,025 million relating to borrowings measured at fair value (2011: EUR 1,010 million).

Commercial paper, Short term deposits and Bank overdrafts vary with the normal course of business.

22. Commitments and contingencies

In Q2 2012, AEGON decided to bring forward the measures related to the agreement announced on July 13, 2009 and reduce future costs for its customers with unit-linked insurance policies. With these measures, AEGON commits to 'best of class' principles of the Dutch Ministry of Finance. Previously, AEGON's approach was to settle compensation with clients when the policy expires. However, to comply with the Ministry's principles, AEGON will now settle compensation immediately by making direct additions to policy values before year-end 2012. As a result of this acceleration of previously announced measures, AEGON has recorded a charge of EUR 265 million before tax in the second quarter of 2012 included in Claims and Benefits.

In addition, AEGON will reduce future policy costs beginning in 2013 onward for the large majority of its unit-linked portfolio. This will decrease income before tax over the remaining duration of the policies by approximately EUR 125 million, based on the current present value.

There have been no other material changes in contingent assets and liabilities as reported in the 2011 consolidated financial statements of AEGON.

23. Acquisitions / Divestments

AEGON signed an agreement to dispose of its interest in Prisma Capital Partners LP ("Prisma") to KKR. Prisma, which is accounted for as an associate, serves as an investment manager for certain of AEGON's hedge fund investments as well as for other third parties. The transaction is expected to close in the fourth quarter of 2012 and is subject to regulatory approval and other closing commitments. The book value as at June 30, 2012 was nil. AEGON's share in Prisma earnings amounted to EUR 5 million for the first six months of 2012 (full year 2011: EUR 13 million).

There were no other significant acquisitions or divestments during the first six months of 2012.

24. Events after the balance sheet date

On July 18, 2012, AEGON issued EUR 500 million in senior unsecured notes, due July 18, 2017. The notes were issued under AEGON's USD 6 billion debt issuance program at a price of 99.712%, and will carry a coupon of 3.00%. Net proceeds from this issuance will be used for general corporate purposes and the redemption of short-term debt.

Following the announced merger between Banca Cívica and CaixaBank in Spain, AEGON reached an agreement, on August 3, 2012, with CaixaBank to end the life, health and pension partnership with Banca Cívica and sell its 50% interest in the joint ventures to CaixaBank for a total consideration of EUR 190 million. The transaction is expected to close in the third quarter of 2012 and is subject to regulatory approvals. The sale is expected to result in a book gain of approximately EUR 35 million before tax. AEGON's share in underlying earnings before tax of the joint venture totaled EUR 9 million for the first six months of 2012 (full year 2011: EUR 16 million).

There were no other events after the balance sheet date with a significant impact on the financial position of the Company as of June 30, 2012.

Local knowledge. Global power.

Unaudited


Management statement

The interim report for the six months ended June 30, 2012 consists of the condensed consolidated interim financial statements, the Q2 results release and the responsibility statement by the Company's Executive Board. The information in this interim report is unaudited.

The Executive Board is responsible for preparing the condensed consolidated interim financial statements in accordance with Dutch law and those International Financial Reporting Standards (IFRS) as adopted by the European Union (EU) and with IFRS as issued by the International Accounting Standards Board (IASB).

The Executive Board declares that, to the best of its knowledge, the condensed consolidated interim financial statements which have been prepared in accordance with IAS 34, "Interim Financial Reporting", as adopted by the EU, with IFRS as issued by the IASB, give a true and fair view of the assets, liabilities, financial condition and profit or loss of AEGON N.V. and the undertakings included in the consolidation as a whole and that the Q2 results release includes a fair review of the information required pursuant to section 5:25d, subsections 8 and 9 of the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht).

The Hague, August 8, 2012

A.R. Wynaendts
Chairman of the Executive Board and CEO

J.J. Nooitgedagt
Member of the Executive Board and CFO

Unaudited
AEGON
page 21


To: The Supervisory Board and the Executive Board of AEGON N.V.

Review report

Introduction

We have reviewed the accompanying condensed consolidated interim financial statements for the six month period ended June 30, 2012 of AEGON N.V., The Hague, as set out on pages 2 to 20, which comprises the condensed consolidated statement of financial position as at June 30, 2012, the condensed consolidated income statement, the condensed consolidated statement of comprehensive income, the condensed consolidated cash flow statement, the condensed consolidated statement of changes in equity and the related notes for the six month period then ended. We have not reviewed the income statement, the statement of comprehensive income and the statement of changes in equity for the three month period ended as at June 30, 2012 and 2011. Management is responsible for the preparation and presentation of these condensed consolidated interim financial statements in accordance with IAS 34, 'Interim Financial Reporting' as adopted by the European Union and as issued by the International Accounting Standards Board. Our responsibility is to express a conclusion on these condensed consolidated interim financial statements based on our review.

Scope of Review

We conducted our review in accordance with Dutch law including Standard 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity'. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Dutch auditing standards and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the accompanying condensed consolidated interim financial statements as at and for the six month period ended June 30, 2012 are not prepared, in all material respects, in accordance with IAS 34, 'Interim Financial Reporting', as adopted by the European Union as issued by the International Accounting Standards Board.

The Hague, August 8, 2012

Ernst & Young Accountants LLP

Signed by R.J.W. Lelieveld

Local knowledge. Global power.

Unaudited


Unaudited
AEGON
page 23


Disclaimers

Cautionary note regarding non-GAAP measures

This document includes a non-GAAP financial measure: underlying earnings before tax. The reconciliation of underlying earnings before tax to the most comparable IFRS measure is provided in Note 3 "Segment information" of AEGON's Condensed consolidated interim financial statements. AEGON believes that this non-GAAP measure, together with the IFRS information, provides meaningful supplemental information that AEGON's management uses to run its business as well as useful information for the investment community to evaluate AEGON's business relative to the businesses of its peers.

Local currencies and constant currency exchange rates

This document contains certain information about investments in USD for the Americas and GBP for the United Kingdom, because those businesses operate and are managed primarily in those currencies. None of this information is a substitute for or superior to financial information about us presented in EUR, which is the currency of AEGON's primary financial statements.

Forward-looking statements

The statements contained in this document that are not historical facts are forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. The following are words that identify such forward-looking statements: aim, believe, estimate, target, intend, may, expect, anticipate, predict, project, counting on, plan, continue, want, forecast, goal, should, would, is confident, will, and similar expressions as they relate to AEGON. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. AEGON undertakes no obligation to publicly update or revise any forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which merely reflect company expectations at the time of writing. Actual results may differ materially from expectations conveyed in forward-looking statements due to changes caused by various risks and uncertainties. Such risks and uncertainties include but are not limited to the following:

  • Changes in general economic conditions, particularly in the United States, the Netherlands and the United Kingdom;
  • Changes in the performance of financial markets, including emerging markets, such as with regard to:
  • The frequency and severity of defaults by issuers in AEGON's fixed income investment portfolios;
  • The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities AEGON holds; and
  • The effects of declining creditworthiness of certain private sector securities and the resulting decline in the value of sovereign exposure that AEGON holds;
  • Changes in the performance of AEGON's investment portfolio and decline in ratings of the company's counterparties;
  • Consequences of a potential (partial) break-up of the euro;
  • The frequency and severity of insured loss events;
  • Changes affecting mortality, morbidity, persistence and other factors that may impact the profitability of AEGON's insurance products;
  • Reinsurers to whom AEGON has ceded significant underwriting risks may fail to meet their obligations;
  • Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates;

  • Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness;

  • Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets;
  • Changes in laws and regulations, particularly those affecting AEGON's operations, ability to hire and retain key personnel, the products the company sells, and the attractiveness of certain products to its consumers;
  • Regulatory changes relating to the insurance industry in the jurisdictions in which AEGON operates;
  • Acts of God, acts of terrorism, acts of war and pandemics;
  • Changes in the policies of central banks and/or governments;
  • Lowering of one or more of AEGON's debt ratings issued by recognized rating organizations and the adverse impact such action may have on the company's ability to raise capital and on its liquidity and financial condition;
  • Lowering of one or more of insurer financial strength ratings of AEGON's insurance subsidiaries and the adverse impact such action may have on the premium writings, policy retention, profitability of its insurance subsidiaries
  • The effect of the European Union's Solvency II requirements and other regulations in other jurisdictions affecting the capital AEGON is required to maintain;
  • Litigation or regulatory action that could require AEGON to pay significant damages or change the way the company does business;
  • As AEGON's operations support complex transactions and are highly dependent on the proper functioning of information technology, a computer system failure or security breach may disrupt the company's business, damage its reputation and adversely affect its results of operations, financial condition and cash flows;
  • Customer responsiveness to both new products and distribution channels;
  • Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for AEGON's products;
  • Changes in accounting regulations and policies may affect AEGON's reported results and shareholder's equity;
  • The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including AEGON's ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions;
  • Catastrophic events, either manmade or by nature, could result in material losses and significantly interrupt AEGON's business; and
  • AEGON's failure to achieve anticipated levels of earnings or operational efficiencies as well as other cost saving initiatives.

Further details of potential risks and uncertainties affecting the company are described in the company's filings with NYSE Euronext Amsterdam and the US Securities and Exchange Commission, including the Annual Report. These forward-looking statements speak only as of the date of this document. Except as required by any applicable law or regulation, the company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Local knowledge. Global power.

Unaudited


Corporate and shareholder information

Headquarters

AEGON N.V.
P.O. Box 85
2501 CB The Hague
The Netherlands
Telephone +31 (0) 70 344 32 10
www.aegon.com

Publication date figures in 2012 and 2013

Thursday, November 8, 2012 Results third quarter 2012
Friday, February 15, 2013 Results fourth quarter 2012
Wednesday, May 8, 2013 Results first quarter 2013
Thursday, August 8, 2013 Results second quarter 2013
Thursday, November 7, 2013 Results third quarter 2013

Group Corporate Communications & Investor Relations

Media relations

Telephone +31 (0) 70 344 89 56
E-mail [email protected]

Investor relations

Telephone +31 (0) 70 344 83 05
or 877 548 96 68 - toll free, USA only
E-mail [email protected]

AEGON's Q2 2012 press release and Financial Supplement are available on www.aegon.com.

Unaudited
AEGON
page 25


About AEGON

Throughout their working lives and into retirement, millions of people around the world rely on AEGON to help them secure their long-term financial futures.

As an international life insurance, pension and asset management company, AEGON has businesses in over twenty markets in the Americas, Europe and Asia. AEGON companies employ approximately 25,000 people and have some 47 million customers across the globe.

AEGON uses its strength and expertise to create added value for customers, shareholders, employees and the wider community. AEGON does this by encouraging innovation and by growing its businesses profitably and sustainably.

AEGON's ambition is to be a leader in all its chosen markets by 2015.

Local knowledge. Global power.